Live
10x Genomics BlogSerge Saxonov (TXG) reports multiple 2026 sales and a 35,270-share RSU grant - Stock Titan10x Genomics BlogTXG (NASDAQ) Form 144: RSU grant 26,276 shares; insider sold 7,826 - Stock Titan10x Genomics NewsAdam Taich files to sell 32,648 shares | TXG SEC Filing - Form 144 - Stock TitanEndpoints NewsFDA clears Gilead's hepatitis D drug, four years after prior rejectionClinical OMICsFungal Adjuvant Mannadjuvant Extends mRNA COVID-19 Vaccine ProtectionsEndpoints NewsGOP lawmaker asks Trump administration to curb China biotech dealsClinical OMICsHow Colorectal Tumors Escape KRAS Inhibitors IdentifiedClinical OMICsFDA Approves Datroway as First-Line Therapy for Triple-Negative Breast CancerBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-May 21, 2026Endpoints NewsAstraZeneca wins EU backing for breast cancer drug, splitting with FDA panelEndpoints NewsHow Utah’s AI prescribing experiment is going so far
Endpoints News Feb 7, 2026

The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more

The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more

Original
Body unavailable. Use the original source.